ACTRN12620000793910已完成未知
Determining the efficacy of a new Prostate Cancer Screening Test combining Circulating Tumour Cells (CTC) and Prostate-Specific Markers: a population-study of 50-75 year old men
AProf Dr Karin Ried0 个研究点目标入组 300 人开始时间: 2020年8月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50 Years 至 75 Years（—）
- 性别
- Male
入选标准
- •Men 50-75 years old
- •Primary group 1: men not diagnosed with cancer
- •Group 2: men diagnosed with prostate cancer (Test will provide probability of relapse or tumour progression)
排除标准
- •men diagnosed with other cancers
研究者
相似试验
招募中
不适用
Evaluation of therapeutic effect on prostate cancer patients with bone metastases using Bone Scan Index (BSI)Prostate cancer patients with bone metastasisJPRN-UMIN000011648Osaka University160
招募中
不适用
Clinical study of prostate cancer dagnositic makers using genetic polymorphismsProstate cancerJPRN-UMIN000019278Kyoto University2,000
尚未招募
不适用
Evaluation of safety and efficacy in prostate cancer patients treated with focal low-dose-rate brachytherapyProstate cancerJPRN-UMIN000030509Kitasato University School of Medicine, Department of Urology20
招募中
Unknown
Detection of clinically significant prostate cancer with MRI-TRUS fusion image-guided biopsy: comparison of the evaluation system (PI-RADS category vs. PI-RADS + US evalutaion)Suspected prostate cancerJPRN-UMIN000050631Tokai University80
已完成
不适用
The study of the treatment efficacy in prostate cancer with low dose abirateroneProstate cancerTCTR20211012001/A21